Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” terminology was removed. The study record continues to display a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-07T11:35:04.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T11:33:37.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A notice appears above the page announcing NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study record itself remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T12:13:03.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T12:38:56.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-10T13:05:26.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page displays a 403 Forbidden error rather than a clinical-trial study record.
    Difference
    0.2%
    Check dated 2026-10-03T14:06:52.000Z thumbnail image

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.